Biotech Showcase™ 2025—17th Annual International Partnering Conference
Biotech Showcase™ is the premier investor and networking conference where private and micro-mid-cap biotechnology companies seize the spotlight to connect with top-tier investors and biopharmaceutical executives. Join over 3,200 global biopharma leaders, including 1,000+ investors and 340+ biotech innovators unveiling their latest breakthroughs. Attendees are expected to participate in more than 6,000 one-on-one meetings, powered by partneringONE™, setting the stage for a year of unparalleled dealmaking.
One-to-one meetings during the conference will be facilitated by the partneringONE platform, ensuring a seamless experience for delegates during both in-person and virtual partnering. An expertly curated program highlighting upcoming developments in the life science industry will be available throughout the conference days. Attendees can expect in-depth discussions on market dealmaking, policy and regulatory landscapes and future therapeutic areas.
Over 300+ top presenting companies are expected to pitch alongside the main program of the event Biotech Showcase will feature seamless integration of two specialized showcases—TechBio Showcase and Seed Showcase—within the main conference, offering unparalled access to the entire life science ecosystem under one roof. Learn more.
Are you a pioneering biotech startup seeking a competitive edge in today's challenging landscape? Learn more and apply to present.
NCLifeSci active members receive a $200 discount on registration or company presentations (excluding seed-stage companies) and a $100 discount on the virtual event. Contact NCLifeSci Events Director Amber Niebauer for the discount code. Learn more.
Biotech Showcase will also be held virtually Jan. 21–22.
NCLifeSci active members receive a $200 discount on registration or company presentations (excluding seed-stage companies) and a $100 discount on the virtual event. Contact NCLifeSci Events Director Amber Niebauer for the discount code. Learn more.